3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Leukemia, Myeloid, Acute
11
Myelodysplastic Syndromes
8
Lymphoma, Non-Hodgkin
7
Hodgkin Disease
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Multiple Myeloma
4
Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Burkitt Lymphoma
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Biphenotypic, Acute
3
Colorectal Neoplasms
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Stomach Neoplasms
2
Sarcoma
2
Primary Myelofibrosis
2
Pancreatic Neoplasms
2
Neoplasm, Residual
2
Myelodysplastic-Myeloproliferative Diseases
2
Melanoma
2
Lymphoma, Follicular
2
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
fludarabine phosphate
×
30 days
×
Clear all
No trials found.